Jabra Enhance Select 500 vs RxEars Rxi

The Jabra Enhance Select 500 is a premium behind-the-ear OTC hearing aid priced at $1,995 that earns an A grade with a SoundScore of 4.2/5 in our lab testing. Ranking #13 of 65 OTC hearing aids tested, it places in the top 18% of its category. This 2024 release demonstrates strong speech-in-quiet performance, scoring 4.3/5—a full 1.50 points above the OTC category average. Speech-in-noise scores 1.8/5, which is above the category average by 0.31 points but remains low in absolute terms, reflecting a common challenge across OTC devices. Feedback handling is excellent at 4.6/5, slightly above the already-high category average. Music streaming scores 2.9/5, which is 0.98 points above the category average but only mixed in absolute terms—adequate for casual listening but not audiophile-quality. Own-voice comfort at 2.2/5 falls 0.31 points below the category average, which may be noticeable for users sensitive to how their voice sounds. The Enhance Select 500 supports iPhone and Android streaming, hands-free calling, and uses rechargeable batteries. It's a solid choice for those prioritizing clear speech in quieter environments and reliable feedback control. However, buyers seeking better value might consider the Jabra Enhance Select 300 or Lucid Engage, which offer similar sound performance at lower price points. This model has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it represents one of the most affordable options in the prescription hearing aid category while still delivering solid overall performance. Speech clarity is a notable strength for this device. In quiet listening environments, the Rxi scores 4.3/5, which is 0.97 points above the category average—a strong result that should benefit users in conversational settings at home or in calm environments. Speech understanding in noisy conditions scores 2.1/5, slightly above the category average by 0.16 points, though this remains mixed in absolute terms and may present challenges in demanding acoustic situations like busy restaurants. Feedback handling is excellent at 4.7/5, essentially matching the category average and indicating reliable stability during daily wear. However, the Rxi shows notable limitations in other areas. Own-voice comfort scores 1.6/5, falling 1.15 points below the category average, which may result in a hollow or boomy perception of your own voice. Music streaming is not supported, scoring 0.0/5—a significant gap of 2.64 points below category average that buyers should consider if streaming audio matters to them. The RxEars Rxi is best suited for budget-conscious consumers who prioritize speech clarity in quieter environments and don't require streaming capabilities. Its invisible form factor and disposable battery design offer convenience, though those seeking better own-voice comfort or music features should explore alternatives.